[1] EBCTCG (Early Breast Cancer Trialists′ Collaborative Group),McGale P,Taylor C,et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality:meta-analysis of individual patient data for 8135 women in 22 randomised trials[J].Lancet,2014,383(9935):2127-2135.DOI:10.1016/ S0140-6736(14)60488-8.
[2] Zhao H,He M,Cheng G,et al. A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT[J].Radiat Oncol, 2015,10(1):231-240.DOI:10.1186/s13014-015-0531-4.
[3] Jin GH,Chen LX,Deng XW,et al. A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques:conventional tangential field, filed-in-filed, Tangential-IMRT,Multi-beam IMRT and VMAT[J].Radiat Oncol,2013,8(1):89-96.DOI:10.1186/1748-717X-8-89.
[4] Haciislamoglu E,Colak F,Canyilmaz E,et al. Dosimetric comparison of left-sided whole-breast irradiation with 3DCRT,forward-planned IMRT,inverse-planned IMRT, helical tomotherapy,and volumetric arc therapy[J].Phys Med,2015,31(4):360-367.DOI:10.1016/j.ejmp.2015.02.005.
[5] Virén T,Heikkil J,Myllyoja K,et al. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy[J].Radiat Oncol,2015,10(1):1-8.DOI:10.1016/j.meddos.2012.04.003.
[6] 蒙渡,刘锐,王书文,等.早期左侧乳腺癌保乳术后IMRT与VMAT两种放射治疗技术的剂量学研究[J].西部医学,2016,28(11):1535-1539.DOI:10.3969/j.issn.1672-3511.2016.11.014.
Meng D,Liu R,Wang SW,et al. Comparing the radioligical dose distribution between VMAT and IMRT applied in radiotherapy of early left breast cancer patients after breast-conserving surgery[J].Med J West China,2016, 28(11):1535-1539.DOI:10.3969/j.issn.1672-3511.2016.11.014.
[7] 张旭,李凯,李娜,等.左乳腺癌保乳术后放疗不同外照射技术所致皮肤受照剂量的比较[J].现代肿瘤医学,2016,24(20):3213-3216.DOI:10.3969/j.issn.1672-4992.2016.20.011.
Zhang X,Li K,Li N,et al. Dosimetric comparison of skin dose for different techniques in left-side breast cancer radiotherapy after breast-conserving surgery[J].Mod Oncol,2016,24(20):3213-3216.DOI:10.3969/j.issn.1672-4992.2016.20.011.
[8] Badakhshi H,Kaul D,Nadobny J,et al. Image-guided volumetric modulated arc therapy for breast cancer:a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy[J].Br J Radiol,2013,86(1032):20130515.DOI:10.1259/bjr.20130515.
[9] Qi XS,Liu TX,Liu AK,et al. Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy[J].Med Dosim,2014,39(3):227-234.DOI:10.1016/j.meddos.2014.02.005.
[10] Liu ZM,Ge XL,Chen JY,et al. Adjuvant Radiotherapy after Breast Conserving Treatment for Breast Cancer:A Dosimetric Comparison between Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy[J].Asian Pac J Cancer,2015,16(8):3257-3265.DOI:10.7314/apjcp.2015.16.8.3257.
[11] Pasler M,Georg D,Bartelt S,et al. Node-positive left-sided breast cancer:does VMAT improve treatment plan quality with respect to IMRT?[J].Strahlenther Onkol,2013,189(5):380-386.DOI:10.1007/s00066-012-0281-2.
[12] Lin JF,Yeh DC,Yeh HL,et al. Dosimetric comparison of hybrid volumetric-modulated arc therapy,volumetric-modulated arc therapy,and intensity-modulated radiation therapy for left-sided early breast cancer[J].Med Dosim,2015,40(3):262-267.DOI:10.1016/j.meddos.2015.05.003.
[13] Kelemen G,Varga Z,Lázár G,et al. Cosmetic outcome 1-5 years after breast conservative surgery,irradiation and systemic therapy[J].Pathol Oncol Res,2012, 18(2):421-427.DOI:10.1007/s12253-011-9462-z.
[14] Lu SH,Cheng JC,Kuo SH,et al. Volumetric modulated arc therapy for nasopharyngeal carcinoma:a dosimetric comparison with TomoTherapy and step-and-shoot IMRT[J].Radiother Oncol,2012,104(3):324-330.DOI:10.1016/j.radonc.2011.11.017.
[15] Deng X,Han C,Chen S,et al. Dosimetric benefits of intensity-modulated radiotherapy and volumetric- modulated arc therapy in the treatment of postoperative cervical cancer patients[J].J Appl Clin Med Phys,2017,18(1):25-31.DOI:10.1002/acm2.12003.
[16] Sardaro A,Petruzzelli MF,D′Errico MP,et al. Radiation-induced cardiac damage in early left breast cancer patients:Risk factors,biological mechanisms, radiobiology,and dosimetric constraints[J].Radiother Oncol,2012,103(2):133-142.DOI:10.1016/j.radonc.2012.02.008.
[17] Bonsignore A,Warburton D.Radiation Therapy and Cardiovascular Disease Risk in Breast Cancer[J].Cur Cardiova Risk Reports,2013,7(6):514-519.DOI:10.1007/s12170-013-0347-4.
[18] Mège A,Ziouèche A,Pourel N,et al.[Radiation-related heart toxicity][J].Cancer Radiother,2011,15(7):495-503.DOI:101016/j.canrad.2011.06.003.
[19] Oie Y,Saito Y, Kato M,et al. Relationship between radiation pneumonitis and organizing pneumonia after radiotherapy for breast cancer[J].Radiat Oncol,2013,8(1):1-6.DOI:10.1186/1748-717X-8-56.
[20] Lee B,Lee S,Sung J,et al. Radiotherapy-induced secondary cancer risk for breast cancer:3D conformal therapy versus IMRT versus VMAT[J].J Radiol Protect, 2014,34(2):325-331.DOI:10.1088/0952-4746/34/2/325. |